More from this Publisher
More from this Publisher
Related Documents
-
Notice: Meetings: Blood Products Advisory Committee
21 reads -
Notice: Organization, functions, and authority delegations: Division of Blood Disorders
35 reads -
Notice: Meetings: Oncologic Drugs Advisory Committee
83 reads -
Notice: Meetings: Pediatric Advisory Committee
39 reads -
Notice: Meetings: Antiviral Drugs Advisory Committee
49 reads -
Notice: Human drugs:
New drug applications— Medical Devices Advisory Committee
54 reads -
Notice: Meetings: Medical Devices Advisory Committee
14 reads -
Notice: Human drugs:
New drug applications— Blood Products Advisory Committee
21 reads -
Notice: Meetings: Anesthetic and Life Support Drugs Advisory Committee
95 reads -
Notice: Meetings: Medical Devices Advisory Committee
52 reads -
Notice: Medical devices:
Patent extension; regulatory review period determinations— Endocrinologic and Metabolic Drugs Advisory Committee
69 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Cardiovascular and Renal Drugs Advisory Committee
88 reads -
Notice: Medical devices: Psychopharmacologic Drugs Advisory Committee
88 reads -
Notice: Meetings: Vaccines and Related Biological Products Advisory Committee
64 reads -
Notice: Federal Food, Drug, and Cosmetic Act: Psychopharmacologic Drugs Advisory Committee
194 reads -
Notice: Human drugs and biological products: Drug Safety and Risk Management Advisory Committee
34 reads -
Notice: Meetings: Science Board
35 reads -
E7-19349
78 reads -
Notice: Meetings: Peripheral and Central Nervous System Drugs Advisory Committee
37 reads -
Notice: Meetings: Cardiovascular and Renal Drugs Advisory Committee
280 reads
Related Documents
Flag this document
2 Pages
